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MAMMARY carcinomas can be induced in virgin IF female mice by means of
chemical carcinogens (Bonser, 1958). But it was shown by Bonser (1954) that
oestrogen alone was not a sufficient substitute for the ovaries as the hormonal
stimulus in the induction of such tumours by methylcholanthrene. However,
by replacement of the ovarian steroid hormones by oestrogen and progesterone,
Jull (1954) was able to obtain 9 tumours in 11 ovariectomised mice. He also
demonstrated (1953) that virgin females of this strain have a well-developed
duct and acinar system, the latter reaching a maximum at about 18 weeks of age
but showing much individual variation. This extensive acinar development
and the demonstration by van der Lee and Boot (1955) that spontaneous pseudo-
pregnancy is frequent in virgins of some mouse strains when the females are
caged in groups, suggested that high levels of progesterone might be operating
in the IF female and might account for the high incidence of breast tumours
induced by chemical carcinogens. It was therefore decided to test the effect
of repeated induced pseudopregnancies on tumour induction by a chemical
carcinogen.
The strain chosen was the BALB/c, which does not carry the milk factor
(Andervont, 1940) and has a low incidence of spontaneous mammary cancer.
The only information available regarding the reaction of this strain to chemical
carcinogens was that obtained by Squartini (1958) who had failed to induce mam-
mary tumours in 30 virgin mice by means of subcutaneous injection of 1 mg.
of 20-methylcholanthrene in 0.2 c.c. of olive oil. There was, therefore, no guide
in regard to the dose and duration ofthe chemical treatment to be adopted. In
order to gain an insight into the mode of action of the chemical, it was decided
to test three groups ofmice: virgins kept five in a cage; virgins deprived ofthe
olfactory lobes and kept singly in order to reduce pseudopregnancy to a minimum
(van der Lee and Boot, 1956); and virgins kept with vasectomised males in order
to induce pseudopregnancy.
MATERIALS AND METHODS
BALB/c strain
A litter ofthis strain was given to the Division of Cancer Research, University
of Perugia, by the Chester Beatty Research Institute, London, in November,
1953. It was then in the 79th generation of inbreeding. The Chester BeattyPSEUDOPREGNANCY AND INDUCTION OF MAMMARY TUMOURS
Institute had previously obtained the strain from L. Dmochowski, Department
of Cancer Research, Leeds, in December, 1952, when it had reached 76 inbred
generations. The donor to Leeds was H. B. Andervont.
During the period in Perugia, this strain has reached the 99th generation
of inbreeding and has shown a low mammary cancer incidence. During 1958,
in 10 virgins there were no tumours and in approximately 40 breeders there were
7.5 per cent, the latent period being 76 weeks or more. During 1959, no tumours
occurred in 44 virgins, but in 44 breeders the incidence was 7.0 per cent at the
same late date. In the hands of Andervont (1941) this strain had an incidence
of mammary cancer in breeding females of less than 2 per cent.
Group I (36 mice).-At 4-5 weeks of age, virgin mice were placed five in a
cage and were so kept throughout the experiment.
Group II (41 mice).-At approximately 6 weeks of age, under ether anaes-
thesia, the olfactory lobes were removed surgically from virgins by means of
suction through small trephine holes in the anterior part of the cranium imme-
diately on either side of the mid-line. The mortality was low (10 per cent).
After recovery the mice were kept five in a cage for approximately one week,
but thereafter they were placed singly in cages.
Group III (32 mice).-At 6 weeks of age, groups of three virgins were mated
with one vasectomised male, which was allowed to remain in the cage throughout
the experiment.
All groups received similar chemical treatment, namely six applications to the
skin at fortnightly intervals of 16 drops of 0-5 per cent 20-methylcholanthrene
(supplied by Messrs. Light & Co. Ltd., Colnbrook, Bucks) in almond oil (8 drops
on the dorsal and 8 on the ventral surface) commencing at 12 weeks of age. It
was computed that 1 ml. of oil, containing 5 mg. of carcinogen, was used for each
application and that the mice were thus exposed to the carcinogen for a period of
12 weeks. The animals stood the treatment well.
A diet of cubes (supplied by Messrs. Pilsbury, Birmingham) and water ad lib.
was given.
At post mortem a whole mount was prepared ofthe third left (thoracic) breast
of each treated mouse. The ovaries with capsule were weighed wet and the
uterine horns were assessed by naked eye examination as normal, increased or
decreased in size.
RESULTS
Mammary tumours
(a) Incidence.-The date of appearance of the mammary tumours and the
survival of the non-tumourous mice are shown in Fig. 1. All the tumours
were single, except in two mice of Group III. In one of these, three tumours
developed at 25 weeks and in the other two tumours at 37 weeks. In Table I
the percentage of mice bearing mammary tumours in relation to survival after
the initiation of treatment is given. No tumours occurred in virgins (Group I),
2-4 per cent in lobectomised virgins (Group II) and 43-8 per cent in females mated
with vasectomised males (Group III). The survival rate was considerably
shorter in the last group, 4 of 32 mice surviving for more than 32 weeks, whereas
the survival was 35 out of 36 and 33 out of41 in the other two groups respectively
(Fig. 1).
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FIG. 1.-Incidence of mammary tumours.
EXPLANATION OF PLATES.
Fic. 2.-Irregular tubular mammary carcinoma (Group III) appearing 25 weeks after the
beginning of treatment. The tubules are irregular in size and shape and there is little
stroma except at bottom right. X 60.
FIG. 3.-Solid polygonal cell mammary carcinoma (Group III) appearing 22 weeks after the
beginning of treatment, with advanced squamous metaplasia. x 60.
FIG. 4.-Papillary cystic mammary carcinoma (Group III) appearing 32 weeks after the
beginning of treatment. X 60.
FIG. 5.-Whole mount of third left breast (Group I) 31 weeks after the beginning oftreatment.
A well-developed pattern of dilated ducts is seen, with no lobules but numerous end buds.
x 60.
FIGa. 6.-Whole mount of third left breast (Group III) 24 weeks after the beginning of treat-
ment. Florid acinar development. This mouse had a mammary tumour in another
breast. x 60.
FIG. 7.-Whole mount of third left breast (Group III) 21 weeks after the beginning of treat-
ment. Nodule at top. x 60.
FIG. 8.-Ovary (Group I) 41 weeks after the beginning of treatment. Atretic follicles round
the edge. Remains of corpora lutea in the interstices with a group of dark-staining cells
in the centre. Pigment-containing phagocytes below centre and top right. x 60.
FIG. 9.-Ovary (Group III) 27 weeks after the beginning of treatment. Atretic follicles
top right and bottom left. Numerous large, old corpora lutea. x 60.
FIG. 10.-Longitudinal section of uterine horn (Group I) 45 weeks after the beginning of
treatment. Lumen narrow with simple crypts dipping into stroma and simple tubular
glands. x 60.
FIG. 11.-Longitudinal section ofuterine horn (GroupIII) 27 weeksafter thebeginning oftreat-
ment. Lumen irregular with irregular crypts dipping into stroma. Large number of
glandular cross sections. x 60.
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TABLE I.-Incidence ofMammary Tumours in Mice Surviving
to the Beginning of Each Ten-week Period
Weeks of survival following
initiation of treatment
r'k _%- Tumours
Group 10-19 20-29 30-39 40-49 50-59 Total (per cent)
I . 36 36 36 22 1 0/36 . 0
II . 41 41 1/37 18 0 . 1/41 2.4
III . 3/32 5/29 6/11 0 0 . 14/34 . 43 8
Numerator = number of mice bearing mammary tumours.
Denominator = number of mice surviving to the beginning of the stated period.
(b) Histological structure.-Using the classification adopted by Bonser (1954),
the mammary tumours in Group III were classified as follows (Fig. 2-4): irregular
tubular 11 (6 with squamous metaplasia and five without), solid polygonal cell
four (all with squamous metaplasia), and two papillary cystic tumours (one with
early squamous metaplasia). No carcinosarcomas occurred. The one tumour
which appeared in Group II was of solid polygonal-cell type, with squamous
metaplasia. Emboli of tumour cells were present in some of the perivascular
lymphatics of one lung.
Structure of the breast
This was assessed by the examination of the whole mounts. No differences
could be detected in the breasts of Groups I and II. The duct system was well
developed, individual ducts were generally slightly dilated, subsidiary ducts were
small in number, end buds were prominent but acini were few (Fig. 5) and only
in two mice were small lobules seen. In two other mice single "nodules" were
seen. By contrast, the breasts of Group III showed florid acinar development,
the main ducts were often greatly dilated (especially towards the nipple) and
nodules were present in all but one of the mice (Fig. 6 and 7). The latter were
numerous, except in 4 mice in which one or two nodules only occurred.
Skin Tumours
Squamous papillomas and carcinomas of the skin occurred very frequently
in anysite in allgroups. The larger carcinomas usuallyulcerated andthusreduced
the life span of the animal.
Lung tumours
Pulmonary adenomas, usually multiple, occurred in all groups usually remain-
ing small in size.
Ovaries
(a) Weight.-Those of Group III were significantly heavier than those of the
other two groups (Table II). The range in all groups was considerable.
(b) Histological structure.-There was a marked difference in the appearance
of the ovaries in Groups I and II compared with Group III. In the former,
atretic follicles in various phases and broken-up remnants of corpora lutea were
seen (Fig. 8). Entirely normal follicles were absent, though some young follicles
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TABLE II.-Ovarian Weights and Uterine Volume
Ovary Uterus
Number Average Range Number Increased Normal Decreased
Group of mice (mg.) (mg.) of mice volume volume volume
I . 36 0-011 0-003-0'027 . 36 10 10 16
II . 41 0-010 0 003-0 020 . 41 2 8 31
III . 32 0.018 0*009-0*030 . 32 26 5 1
showed only a damaged ovum. Corpora lutea were present only in occasional
mice of Group I. In the ovaries of Group III, atretic follicles were present in
numbers approximating to those in the other two groups, as well as large numbers
oflarge corpora lutea (Fig. 9). The lutein cells stained dark pink with eosin and
were judged to be old structures. Although occasional luteomatous proliferations
were seen in the ovaries of all groups, no ovarian tumours were detected.
Uterus
(a) Volume.-The uterus was inspected at post mortem and an assessment
was made of the size of the horns (Table II). In Group I the horns were either
thread-like, normal or slightly increased in volume; in Group II they were usually
thread-like, whereas in Group III they were often thick and dilated.
(b) Histological structure.-The uteri ofGroups I and II had a structure charac-
teristic of the virgin mouse, the endometrium being composed of a single lining
layer of columnar cells placed on dense stroma, into which dipped small numbers
of simple tubular glands. The lumen was narrow, with occasional crypt-like
depressions into the stroma (Fig. 10). The uteri of Group III showed a very
different picture. There was no exoess of stroma and the component cells were
not swollen, but the amount of surface epithelium was greatly increased by num-
erous irregular clefts which dipped into the stroma and gave the lumen a papillary
aspect (Fig. 11). The number of cross-sections of tubular glands was increased,
due either to an increase in the actual number ofglands or to a more complicated
structure of those present. Penetration of the endometrial glands into the
muscular coat did not occur.
DISCUSSION
The present experiments have demonstrated that intact or lobectomised
virgins of the BALB/c strain, which is free ofthe milk factor and has a low spon-
taneous incidence of mammary cancer, do not develop mammary tumours when
treated with a dose of methylcholanthrene which is known to be in excess of that
required to induce tumours in virgins of the IF strain. Jull (1956), using a
standard limited dose of 4 applications to the skin of an oily solution of the
compound, obtained 6 mammary tumours in 16 IF mice (38 per cent).
When pseudopregnancy was induced by mating females with vasectomised
males (Group III) 44 per cent developed mammary tumours, the induction period
ranging from 16-37 weeks following the initiation of treatment, a result closely
comparable to that obtained by Jull in IF virgins. Thus the hormonal conditions
of pseudopregnancy act as a promoting agent for the induction of mammary
tumours in BALB/c breasts already submitted to the initiating action of a carcin-
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ogen. This type of promoting stimulus is not essential for the induction of
mammary tumours in this strain by the milk factor for Severi, Olivi and Bianci-
fiori (1958) found an incidence of 54 per cent of mammary tumours in virgins
at an average age of 50 weeks in BALB/c mice which had been given milk factor
by Andervont in 1940 (called BALB/c+ in Perugia).
The florid structure of the breasts, the large number of corpora lutea in the
ovaries and the hyperplastic state of the endometrium constitute evidence that
the mice placed with vasectomised males were under the influence of oestrogen-
progesterone secretion. Thus these experiments provide further evidence that
the carcinogenic action of methylcholanthrene on the mouse breast is augmented
by oestrogen combined with progesterone.
The absence of tumours in intact and lobectomised virgins was not due to
short survival in these groups, for they lived a good deal longer than the pseudo-
pregnant mice (Fig. 1). It might be suggested that pseudopregnancy alone was
the cause of the mammary tumours and that initiation by the chemical was an
unnecessary factor. This seems unlikely, as mammary tumours occur spontane-
ously in low yield only, in old breeders of this strain. It is a point which is,
however, under investigation.
No attempt was made to study the histogenesis of the mammary tumours in
Group III but the presence of large numbers of typical hyperplastic nodules in
the breasts is in keeping with van Rijssel's (1956) demonstration that in mice with
the milk agent there is a relation between the number ofthese structures and the
subsequent appearance of the fully formed tumours. He calculated that about
60 nodules were necessary for every palpable tumour that presented.
The morphology of the induced tumours was similar to that of chemically-
induced tumours of the IF strain. The predominant tumour was the irregular
tubular adenocarcinoma, which may be regarded as the characteristic tumour of
chemical induction, but solid polygonal andpapillary cystic tumours also occurred.
In two thirds there was squamous metaplasia, thought by Bonser (1958) to be
associated with excessive dosage of the chemical. Although carcinosarcomas
were not found, this type of tumour is not uncommon in IF mice treated with
methylcholanthrene or 1: 2: 5: 6-dibenzanthracene.
SUMMARY
Three groups of females of the BALB/c strain (with low breast cancer inci-
dence and no milk factor) were treated with 20-methylcholanthrene applied to
the skin in oily solution.
In Group I (36 virgins kept 5 in a cage) no mammary tumours occurred,
although the mice survived for a period greater than 30 weeks after the beginning
of treatment. In Group II (41 virgins with olfactory lobes removed) there was
one mammary tumour 36 weeks following the initiation of treatment, 37 mice
having survived for 30 weeks or more. In Group III (32 females kept 3 in a cage
with a vasectomised male) the incidence ofmammary tumours was 43-8 per cent,
the latent period being 16-37 weeks. Benign and malignant tumours of the
skin and lung adenomas occurred in all groups.
In the mice of Group III there was evidence of the excessive hormonal stimu-
lation ofpseudopregnancy in the florid structure ofthe breasts, the large number
ofcorpora lutea in the ovaries and the hyperplasia ofthe uterine endometrium.
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It is postulated that the hormonal stimulation ofpseudopregnancy, through
oestrogen and progesterone, acted as the promoting agent in the causation of
mammary tumours in breasts which had been subjected to the initiating action
ofmethylcholanthrene.
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